Advertisement
Advertisement
U.S. Markets open in 6 hrs 27 mins
Advertisement
Advertisement
Advertisement
Advertisement

MusclePharm Corporation (MSLP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2400-0.0300 (-11.11%)
At close: 03:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2700
Open0.1520
BidN/A x N/A
AskN/A x N/A
Day's Range0.1520 - 0.2400
52 Week Range0.1400 - 3.0000
Volume1,201
Avg. Volume30,818
Market Cap8.013M
Beta (5Y Monthly)0.24
PE Ratio (TTM)N/A
EPS (TTM)-0.0990
Earnings DateMar 28, 2022 - Apr 01, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    MusclePharm Announces First Quarter 2022 Financial Results

    Company Revenue Increases 31% Sequentially to $13.1 Million in First Quarter of 2022 Second Consecutive Quarter of Margin Improvement Despite Industry-Wide Supply Challenges Company Triples MP Performance Energy Sales in First Quarter of 2022 from Fourth Quarter of 2021 to Over $1.1 Million; Delivers Energy Margins of 35% in First Quarter of 2022 LAS VEGAS, May 16, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCMKTS: MSLP), a global provider of leading spor

  • GlobeNewswire

    MusclePharm to Announce First Quarter 2022 Financial Results on Monday, May 16, 2022

    LAS VEGAS, May 10, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCMKTS: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, announced today that the Company will report its financial results for the first quarter ended March 31, 2022, after the market closes on Monday, May 16, 2022. The Company will host a conference call to discuss its operating results on Monday, May 16, 2022, at 1:30 pm Pacific Time (4:30 p

  • GlobeNewswire

    Correction: MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial Results

    Company Delivers $10.0 Million of Net Revenue in Fourth Quarter 2021 and $50.0 Million of Net Revenue for Full Year 2021 Operating Expenses Decline $2.7 Million or 16% for Full Year 2021 Company Sells More Than 1.4 Million Cans of MP Performance Energy Since Launch; Delivers Fourth Quarter 2021 Energy Margins of 35% and Full Year 2021 Energy Margins of 45% LAS VEGAS, May 05, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation is issuing this press release to correct its press release dated April 14

Advertisement
Advertisement